Daniel Afar
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 30
- Multiple Myeloma Research and Treatments 17
- Chronic Myeloid Leukemia Treatments 10
- Oncology 22
- Lung Cancer Research Studies 5
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Owen N. Witte (13 shared papers)Jami McLaughlin (6 shared papers)Andrei Goga (6 shared papers)Douglas C. Saffran (4 shared papers)John Cameron Bell (10 shared papers)Owen N. Witte (3 shared papers)Anil K. Singhal (4 shared papers)Arthur B. Raitano (2 shared papers)
- Journals
- Blood (14 papers)Molecular and Cellular Biology (7 papers)Annals of Oncology (5 papers)Proceedings of the National Academy of Sciences (5 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Daniel Afar
68 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 107
- Hematology 2.1k
- Genetics 887
- Oncology 1.6k
- Immunology 1.1k
- Molecular Biology 2.3k
Countries citing papers authored by Daniel Afar
This map shows the geographic impact of Daniel Afar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Afar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Afar more than expected).
Fields of papers citing papers by Daniel Afar
This network shows the impact of papers produced by Daniel Afar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Afar. The network helps show where Daniel Afar may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Afar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 475 | |
| 2 | 2007 | 410 | |
| 3 | 1996 | 312 | |
| 4 | 1999 | 305 | |
| 5 | 2011 | 301 | |
| 6 | 1996 | 271 | |
| 7 | 1995 | 223 | |
| 8 | Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. | 2001 | 219 |
| 9 | 1998 | 203 | |
| 10 | Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. | 2003 | 202 |
| 11 | 2012 | 170 | |
| 12 | 1994 | 166 | |
| 13 | 2009 | 150 | |
| 14 | 2018 | 122 | |
| 15 | 1994 | 109 | |
| 16 | 1991 | 108 | |
| 17 | 1997 | 98 | |
| 18 | 2003 | 97 | |
| 19 | 1996 | 96 | |
| 20 | 1996 | 79 |
About Daniel Afar
Daniel Afar is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Molecular Biology, having authored 69 papers that have together received 5.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (17 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers), Glycosylation and Glycoproteins Research (8 papers), Ubiquitin and proteasome pathways (7 papers), Lung Cancer Research Studies (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (887 citations), Oncology (1.6k citations), Immunology (1.1k citations) and Molecular Biology (2.3k citations). Daniel Afar has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Owen N. Witte, Jami McLaughlin, Andrei Goga, Douglas C. Saffran, John Cameron Bell, Owen N. Witte, Anil K. Singhal, Arthur B. Raitano, Aya Jakobovits and Emily Chen. Their work appears in journals such as Blood, Molecular and Cellular Biology, Annals of Oncology, Proceedings of the National Academy of Sciences and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.